-
Publication Venue For
-
Association of Changes in Medicaid Dental Benefits With Localized Diagnosis of Oral Cavity Cancer..
8:778-780.
2022
-
Diagnosis and Treatment of ERBB2-Positive Metastatic Colorectal Cancer: A Review..
8:760-769.
2022
-
Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer..
8:687-696.
2022
-
Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma..
7:1815-1823.
2021
-
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study..
7:1856-1861.
2021
-
Compliance With Price Transparency Rules at US National Cancer Institute-Designated Cancer Centers..
7:1903-1904.
2021
-
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer..
7:1644-1652.
2021
-
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical Trial..
7:1536-1543.
2021
-
Estimated Performance of Transvaginal Ultrasonography for Evaluation of Postmenopausal Bleeding in a Simulated Cohort of Black and White Women in the US..
7:1158-1165.
2021
-
Considerations Regarding a Network Meta-analysis of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer-Reply..
7:1069-1070.
2021
-
Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases: Findings From the NRG-BR001 Phase 1 Trial..
7:845-852.
2021
-
Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia-Moving From Evidence to Practice-Reply..
7:943-944.
2021
-
Vulnerable Older Adults With Ovarian Cancer-Time to Stop Undertreating..
7:831-833.
2021
-
Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis..
7:412-420.
2021
-
Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia: A Randomized Clinical Trial..
7:238-245.
2021
-
Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial..
7:42-50.
2021
-
Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer..
6:1713-1721.
2020
-
Association of Sedentary Behavior With Cancer Mortality in Middle-aged and Older US Adults..
6:1210-1217.
2020
-
De-Escalating Breast Cancer Surgery for Low-Risk Ductal Carcinoma in Situ..
6:1117-1118.
2020
-
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial..
6:1003-1010.
2020
-
Incidence of Opioid-Associated Deaths in Cancer Survivors in the United States, 2006-2016: A Population Study of the Opioid Epidemic..
6:1100-1102.
2020
-
Association Between Breastfeeding and Ovarian Cancer Risk..
6:e200421.
2020
-
Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer..
6:735-743.
2020
-
Changing the Course of Cancer Care With Greater Precision..
6:634-636.
2020
-
Global Retinoblastoma Presentation and Analysis by National Income Level..
6:685-695.
2020
-
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma..
6:495-503.
2020
-
Life Expectancy of Adult Survivors of Childhood Cancer Over 3 Decades..
6:350-357.
2020
-
Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials..
6:217-225.
2020
-
Exercise and Patients With Cancer-Is It Time to Get Heavier With the Dose?.
6:301.
2020
-
Additional Lumpectomy and Irradiation for In-Breast Recurrence of Cancer-When Less Is More..
6:82-83.
2020
-
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial..
6:60-67.
2020
-
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer..
5:1790-1798.
2019
-
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study..
5:1749-1768.
2019
-
Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial..
5:1582-1588.
2019
-
Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial..
5:1431-1438.
2019
-
Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial..
5:1448-1455.
2019
-
Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality..
5:975-983.
2019
-
Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity..
5:864-871.
2019
-
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial..
5:664-670.
2019
-
Assessing the Prognostic Value of the Automated Bone Scan Index for Prostate Cancer-Reply..
5:270-271.
2019
-
Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical Trial..
5:195-203.
2019
-
Engaging Patients in Value-Based Cancer Care: A Missed Opportunity..
4:1479-1480.
2018
-
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study..
4:1553-1568.
2018
-
Information Transparency in the Drug Approval Process..
4:1621-1622.
2018
-
Association of Exercise With Mortality in Adult Survivors of Childhood Cancer..
4:1352-1358.
2018
-
Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014..
4:1254-1262.
2018
-
Broadening the View of Germline Mutations in Kidney Cancer..
4:1235-1236.
2018
-
Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial..
4:944-951.
2018
-
Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial..
4:783-790.
2018
-
Study Limitations in HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia-Reply..
4:891.
2018
-
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features..
4:e175230.
2018
-
"Job Lock" Among Long-term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study..
4:707-711.
2018
-
Radiographic Progression-Free Survival as a Clinically Meaningful End Point in Metastatic Castration-Resistant Prostate Cancer: The PREVAIL Randomized Clinical Trial..
4:694-701.
2018
-
Seizure Rates in Enzalutamide-Treated Men With Metastatic Castration-Resistant Prostate Cancer and Risk of Seizure: The UPWARD Study..
4:702-706.
2018
-
Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer..
4:564-568.
2018
-
Technological Advances, Biologic Rationales, and the Associated Success of Chemotherapy With Hyperthermia in Improved Outcomes in Patients With Sarcoma..
4:493-494.
2018
-
Minimal Residual Disease in Chronic Lymphocytic Leukemia in the Era of Novel Agents: A Review..
4:394-400.
2018
-
Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)..
4:190-195.
2018
-
Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial..
4:196-202.
2018
-
Primary Cancer vs Competing Causes of Death in Survivors of Head and Neck Cancer..
4:257-259.
2018
-
HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest Group..
4:54-62.
2018
-
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015..
3:1683-1691.
2017
-
Out-of-Pocket Costs, Financial Distress, and Underinsurance in Cancer Care..
3:1582-1584.
2017
-
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study..
3:e172411.
2017
-
Comparison of Patient Report and Medical Records of Comorbidities: Results From a Population-Based Cohort of Patients With Prostate Cancer..
3:1035-1042.
2017
-
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033..
3:944-952.
2017
-
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)..
3:827-831.
2017
-
Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study..
3:636-651.
2017
-
Appropriate Use of Antiemetics to Prevent Chemotherapy-Induced Nausea and Vomiting..
3:307-309.
2017
-
Association of a Bundled-Payment Program With Cost and Outcomes in Full-Cycle Breast Cancer Care..
3:327-334.
2017
-
Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes: A Meta-Analysis..
2:751-760.
2016
-
Risk Model-Guided Antiemetic Prophylaxis vs Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Randomized Clinical Trial..
2:225-231.
2016
-
Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1..
1:1319-1323.
2015
-
Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009..
1:1098-1109.
2015
-
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)..
1:1051-1059.
2015
-
Chemotherapy Use, Performance Status, and Quality of Life at the End of Life..
1:778-784.
2015
-
The Global Burden of Cancer 2013..
1:505-527.
2015
-
Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study..
1:204-212.
2015
-
Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009..
1:158-166.
2015
-
Midlife Cardiorespiratory Fitness, Incident Cancer, and Survival After Cancer in Men: The Cooper Center Longitudinal Study..
1:231-237.
2015